Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
HypnoVR Raises €4.5 Million to Accelerate the Roll Out of its Digital Therapy Treating Pain and Anxiety
HypnoVR, a market leader in the field of digital therapies to manage pain and stress, […]
Metrion Biosciences Expands Ion Channel Drug Discovery Service Capabilities and In-house Expertise
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today […]
Genoskin Launches MANTIS, a Spatial Biology Imaging Platform Dedicated to Skin Immunology
Genoskin, a biotechnology company that leverages live ex vivo human skin to test therapeutic and non-therapeutic products, […]
Vinehealth Raises $5.5m to Improve the Quality of Life and Survival of Cancer Patients
Today, Vinehealth announces it has raised $5.5m in seed funding. The round was led by […]
Holmusk Announces Closing of Strategic Investment from Healthcare and Life Science Industry Leaders
Holmusk, a leading global data science and digital health company building the world’s largest Real-World […]
Roche to Launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in Countries Accepting the CE Mark to Enable Rapid Differentiation of Viral Respiratory Infections
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu […]
PDC*line Pharma Raises €17.5 Million ($20.3M) in Series B2 Financing Round
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable […]
Amphista Therapeutics Appoints Dr Martin Pass as CDO
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]
Sixfold Bioscience Completes $10.5M USD (£7.8M GBP) Seed Financing
Sixfold Bioscience (Sixfold), a company harnessing computation and advanced chemistry to design RNA therapeutic delivery […]
MHRA Approves Xevudy (sotrovimab), a COVID-19 Treatment Found to Cut Hospitalisation and Death by 79%
Another COVID-19 treatment, Xevudy (sotrovimab), has today been approved by the Medicines and Healthcare products […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more